Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 07, 2021

SELL
$116.57 - $155.01 $818,671 - $1.09 Million
-7,023 Closed
0 $0
Q4 2020

Feb 09, 2021

SELL
$99.61 - $142.12 $103,494 - $147,662
-1,039 Reduced 12.89%
7,023 $930,000
Q3 2020

Nov 09, 2020

SELL
$72.92 - $102.01 $522,034 - $730,289
-7,159 Reduced 47.03%
8,062 $822,000
Q2 2020

Aug 14, 2020

BUY
$55.75 - $92.75 $346,820 - $576,997
6,221 Added 69.12%
15,221 $1.32 Million
Q4 2019

Feb 03, 2020

SELL
$77.66 - $99.74 $543 - $698
-7 Reduced 0.08%
9,000 $832,000
Q3 2019

Oct 29, 2019

BUY
$90.37 - $122.49 $632 - $857
7 Added 0.08%
9,007 $813,000
Q2 2019

Jul 18, 2019

SELL
$89.51 - $118.04 $89,510 - $118,040
-1,000 Reduced 10.0%
9,000 $1.06 Million
Q2 2018

Jul 30, 2018

SELL
$37.84 - $69.96 $1,513 - $2,798
-40 Reduced 0.4%
10,000 $598,000
Q1 2018

Apr 23, 2018

BUY
$39.82 - $57.53 $1,592 - $2,301
40 Added 0.4%
10,040 $405,000
Q4 2017

Feb 15, 2018

BUY
$46.49 - $60.51 $464,900 - $605,100
10,000
10,000 $525,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.64B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Main Street Investment Advisors LLC Portfolio

Follow Main Street Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Street Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Main Street Investment Advisors LLC with notifications on news.